4.7 Article

Standardization of analysis sets for reporting results from ADNI MRI data

期刊

ALZHEIMERS & DEMENTIA
卷 9, 期 3, 页码 332-337

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2012.06.004

关键词

Alzheimer's disease; Biomarkers; Magnetic resonance imaging; Analysis standards; ADNI

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. National Institute on Aging
  3. National Institute of Biomedical Imaging and Bioengineering
  4. ADNI clinical sites in Canada
  5. NIH [P30 AG010129, K01 AG030514]
  6. National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish

向作者/读者索取更多资源

The Alzheimer's Disease Neuroimaging Initiative (ADNI) three-dimensional T-1-weighted magnetic resonance imaging (MRI) acquisitions provide a rich data set for developing and testing analysis techniques for extracting structural endpoints. To promote greater rigor in analysis and meaningful comparison of different algorithms, the ADNI MRI Core has created standardized analysis sets of data comprising scans that met minimum quality control requirements. We encourage researchers to test and report their techniques against these data. Standard analysis sets of volumetric scans from ADNI-1 have been created, comprising screening visits, 1-year completers (subjects who all have screening, 6- and 12-month scans), 2-year annual completers (screening, 1-year and 2-year scans), 2-year completers (screening, 6-months, 1-year, 18-months [mild cognitive impaired (MCI) only], and 2-year scans), and complete visits (screening, 6-month, 1-year, 18-month [MCI only], 2-year, and 3-year [normal and MCI only] scans). As the ADNI-GO/ADNI-2 data become available, updated standard analysis sets will be posted regularly. (C) 2013 The Alzheimer's Association. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据